Transforming growth factor-β in thermally injured patients with hypertrophic scars: Effects of interferon α-2b

Plastic and Reconstructive Surgery

Volumn 102, Issue 5, 1998, Pages 1317-1328

  Tredget, Edward E ^a,b   Shankowsky, Heather A ^a   Pannu, Rajeet ^a   Nedelec, Bernadette ^a   Iwashina, Takashi ^a   Ghahary, Aziz ^a   Taerum, Terry V ^a   Scott, Paul G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; N METHYLHISTAMINE; TRANSFORMING GROWTH FACTOR BETA; ANTIHISTAMINIC AGENT;

ARTICLE; BURN SCAR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; FEMALE; FIBROSIS; HISTAMINE RELEASE; HUMAN; HYPERTROPHIC SCAR; MALE; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THERMAL INJURY; TREATMENT OUTCOME; WOUND HEALING; FLU LIKE SYNDROME; NOTE;

ADULT; BURNS; CHILD; CICATRIX, HYPERTROPHIC; FEMALE; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031781939     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199810000-00001     Document Type: Article

References (42)

1. Tredget, E. E., Nedelec, B., Scott, P. G., and Ghahary, A. Hypertrophic scars, keloids and contractures: The cellular and molecular basis for therapy. Surg. Clin. North Am. 77: 701, 1997.
2. Engrav, L. H., Covey, M. H., Dutcher, K. D., et al. Impairment, time out of school, and time off from work after burns. Plast. Reconstr. Surg. 79: 927, 1987.
3. Hayakawa, T., Hashimoto, Y., Myokei, Y., Aoyama, H., and Izawa, Y. Changes in type of collagen during the development of human post-burn hypertrophic scars. Clin. Chim. Acta 93: 119, 1979.
4. Linares, H. A., Kischer, W. C., Dobrkovsky, M., and Larson, D. L. The histiotypic organization of the hypertrophic scar in humans. J. Invest. Dermatol. 59: 323, 1972.
5. Roberts, A. B., Sporn, M. B., Assoian, R. K., et al. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 83: 4167, 1986.
6. Westergren-Thorsson, G., Antonsson, P., Malmstrom, A., Heinegard, D., and Oldberg, A. The synthesis of a family of structurally related proteoglycans in fibroblasts is differently regulated by TGF-β. Matrix 11: 177, 1991.
7. Edwards, D. R., Murphy, G., Reynolds, J. J., et al. Transforming growth factor-beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6: 1899, 1987.
8. Overall, C., Wrana, J. L., and Sodeck, J. Independent regulation of collagenase, 72-kDa progelatinase and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J. Biol. Chem. 264: 1860, 1989.
9. Khalil, N., O'Connor, R. N., Unruh, H. W., Warren, P. W., Flanders, K. C., and Kemp, A. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5: 155, 1991.
10. 1 and α in chronic liver disease: Effect of interferon α therapy. N. Engl. J. Med. 324: 933, 1991.
11. Border, W. A., Noble, N. A., Yamamoto, T., et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360: 361, 1992.
12. Caver, T. E., O'Sullivan, F. X., Gold, L. I., and Gresham, H. D. Intracellular demonstration of active TGF-β1 in B cells and plasma cells of autoimmune mice. J. Clin. Invest. 98: 2496, 1996.
13. Schultz-Cherry, S., Chen, H., Mosher, D. F., et al. Regulation of transforming growth factor-beta; activation by discrete sequences of thrombospondin 1. J. Biol. Chem. 270: 7304, 1995.
14. 1 autoinduction. J. Biol. Chem. 264: 7041, 1989.
15. Anscher, M. S., Peters, W. P., Reisenbichler, H., Petros, W. P., and Jirtle, R. L. Transforming growth factor-β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N. Engl. J. Med. 328: 1592, 1993.
16. 1 expression in irradiated liver. Radiat. Res. 122: 77, 1990.
17. 1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci. 107: 1137, 1994.
18. Wahl, S. M. Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure. J. Clin. Immunol. 12: 61, 1992.
19. Nedelec, B., Dodd, C., Shen, Y. J., Ghahary, A., Scott, P. G., and Tredget, E. E. Interferon α-2b inhibits wound contraction in vivo. Wound Rep. Reg. (in press).
20. Unemori, E. N., Pickford, L. B., Salles, A. L., et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J. Clin. Invest. 98: 2739, 1996.
21. Ezekowitz, R. A. B., Mulliken, J. B., and Folkman, J. Interferon α-2A therapy for life threatening hemangiomas of infancy. N. Engl. J. Med. 326: 1456, 1992.
22. Kluin-Nelemans, H. C., Jansen, J. H., Breukelman, H., et al. Response to interferon α-2b in a patient with systemic mastocytosis. N. Engl. J. Med. 326: 619, 1992.
23. Granerus, G., Lonnqvist, B., and Roupe, G. Histamine metabolism in mastocytosis patients treated with interferon alfa-2b. Inflamm. Res. 45 (Suppl.): S41, 1996.
24. Granstein, R. D., Murphy, G. F., Margolis, R. J., Byrne, M. H., and Amento, E. P. Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J. Clin. Invest. 79: 1254, 1987.
25. Davis, G. L., Balart, L. A., Schiff, E. R., et al. Treatment of chronic hepatitis C with recombinant interferon α: A multicentre trial. N. Engl. J. Med. 321: 1501, 1989.
26. Engrav, L. H., Dutcher, K. A., and Nakamura, D. Y. Rating burn impairment. Clin. Plast. Surg. 19: 569, 1992.
27. Ahn, S. T., Monafo, W. W., and Mustoe, T. A. Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch. Surg. 126: 499, 1991.
28. Danielpour, D. Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor betal. J. Immunol. Methods 158: 17, 1993.
29. Grainger, D. J., Mosedale, D. E., Metcalfe, J. C., Weissberg, P. L., and Kemp, P. R. Active and acid-activatable TGF-β in human sera, platelets and plasma. Clin. Chim. Acta 235: 11, 1995.
30. τ-methylhistamine in vivo by isotope dilution using benchtop gas chromatography-mass spectrometry. J. Chromatogr. B. Biomed. Sci. Appl. 694: 1, 1997.
31. τ-methylhistamine from biological fluids. Appl. Radiat. Isot. 48: 1187, 1997.
32. Grainger, D. J., Mosedale, D. E., Metcalfe, J. C., Weissberg, P. L., and Kemp, P. R. Active and acid-activatable TGF-β in human sera platelets and plasma. Clin. Chim. Acta 235: 11, 1995.
33. Sanderson, N., Factor, V., Nagy, P., et al. Hepatic expression of mature transforming growth factor betal in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. U.S.A. 92: 2572, 1995.
34. Vitale, M., Fields-Blache, C., and Luterman, A. Severe itching in the patient with burns. J. Burn Care Rehabil. 12: 330, 1991.
35. Kischer, C. W., Bunce, H., and Shetlar, M. R. Mast cell analyses in hypertrophic scars, hypertrophic scars treated with pressure and mature scars. J. Invest. Dermatol. 70: 355, 1978.
36. 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270: 4689, 1995.
37. Larrabee, W. F., Jr., East, C. A., Jaffe, H. S., Stephenson, C., and Peterson, K. E. Intralesional interferon γ treatment for keloids and hypertrophic scars. Arch. Otolaryngol. Head Neck Surg. 116: 1159, 1990.
38. McCauley, R. L., Chopra, V., Ying-Yue, L., Herndon, D. N., and Robson, M. C. Altered cytokine production in black patients with keloids. J. Clin. Immunol. 12: 300, 1992.
39. O'Sullivan, S. T., Lederer, J. A., Horgan, A. F., Chin, D. H., Mannick, J. A., and Rodrick, M. L. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222: 482, 1995.
40. Tsubota, A., Chayama, K., Ikeda, K., et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19: 1080, 1994.
41. Muller, H., Hammes, E., Hiemke, C., and Hess, G. Interferon-alpha-2-induced stimulation of ACTH and cortisol secretion in man. Neuroendocrinology 54: 499, 1991.
42. Poynard, T., Leroy, V., Cohard, M., et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. Hepatology 24: 778, 1996.